Biotin (vitamin B7) supplementation may offer protection against manganese-induced brain cell damage, according to a recent study. Manganese is a…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Researchers at the University of Cambridge in the U.K. are developing brain implants using small clusters of lab-grown cells in…
Levels of a retrovirus that entered the human genome via infections millions of years ago — an endogenous retrovirus called…
Aging microglia, the immune cells of the brain that protect it by fighting infections and clearing debris, may mount a…
Approximately two-thirds of Parkinson’s disease patients may experience paranoia and unusual sensations, including visual hallucinations, according to a new…
U.S. researchers have identified, as a potential therapeutic target in Parkinson’s disease, a protein that controls part of the…
C2N Diagnostics and The Michael J. Fox Foundation for Parkinson’s Research (MJFF) are teaming up to study how…
A mobile application that detects a person’s natural walking pace and provides real-time, beat-synchronized music for at-home rehabilitation improved walking…
Aspen Neuroscience has completed dosing the first two groups of patients in ASPIRO, an ongoing Phase 1/2a clinical trial…
BlueRock Therapeutics said it is progressing its investigational cell therapy, bemdaneprocel, into a Phase 3 clinical trial set to…